Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
about
Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiencyInduction of cyclin A gene expression by homocysteine in vascular smooth muscle cellsThe neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemiaHistologic Response to Injected Phosphatidylcholine in Fat Tissue: Experimental Study in a New Rabbit ModelFuture for folates in cardiovascular disease.Homocysteine.Correlation of serum homocysteine levels with the severity of coronary artery disease.A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis.Homocysteine, system b0,+ and the renal epithelial transport and toxicity of inorganic mercury.Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogenPolymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruptionKcne2 deletion causes early-onset nonalcoholic fatty liver disease via iron deficiency anemiaHyperhomocysteinaemia and premature coronary artery disease in the Chinese.Regular exercise training increases the number of endothelial progenitor cells and decreases homocysteine levels in healthy peripheral blood.Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide.Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages.Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation.Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.Homocyst(e)ine and arterial occlusive diseases.Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.The effects of oral vitamin supplementation on cardiovascular risk factors.Hyperhomocyst(e)inemia and atherothrombosis.Homocystinuria: Diagnosis and Neuroimaging Findings of Iranian Pediatric patients.A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis.Homocysteine and major coronary events: a prospective population study amongst women.Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia.Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins.Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics.Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study.Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats.Smooth muscle-associated protein 8: distribution and biological activity in the rat brain.Antiatherogenic and radioprotective role of folic acid in whole body gamma-irradiated mice.Association between elevated plasma total homocysteine and increased common carotid artery wall thicknessHyperhomocysteinemia Predicts the Severity of Coronary Artery Disease as Determined by the SYNTAX Score in Patients with Acute Coronary Syndrome
P2860
Q28207658-CB5D43D7-C539-49E5-B878-46FE45E147D3Q28378757-524A43A1-7F16-4A4C-BB1B-6C7211601F9FQ28506425-718A9C0E-CD4C-4F08-A937-20F9D6673582Q29395599-07EA46F6-0EFC-431E-9DC8-E07C7F780B05Q33717464-EAD7A2E0-0D2E-4395-844B-CBF87B5E82CDQ33732664-C1D14996-33B3-4146-8A8A-E30E1C4F584CQ33774591-832B5072-0B8D-45EC-8F58-92655840A00BQ34409861-1A3E15B4-84CD-447D-893B-05B4412CDDE9Q35103270-08736D0A-4904-4BC6-BE84-939EF65970FFQ35571273-37BDD1B3-5B3E-4A92-AC7D-980021675598Q35824103-72A31321-BBAC-410F-BFC8-DD01D9C9F547Q35828504-85758999-35F2-47B8-81F2-FBC53AC115ADQ36694213-D877546F-6A2A-4C54-9B57-1075DAFACAE9Q36834312-0FE17CE3-5BF2-41A5-B9D7-5BC13161CEE6Q37714631-5405DD6F-0F2E-40FB-8632-A0F583DE04C5Q37969222-1C2F51F0-2253-4A54-89F0-C4AAD55D72D9Q38896912-414A20A9-02F1-42C0-9024-BB063E6CA907Q40255028-87FFB0D7-2A0E-4744-B58C-BD1E2A5D8053Q40290005-CB04758F-069C-4E8A-81C0-FFA912E088FBQ40304955-7130A831-1613-4EA6-B43C-7E94686BB795Q40649186-C43F1758-9367-4728-89F1-E42B9DD19ABCQ41208237-264D9E8B-9D23-49F5-8ACC-1BFBABCEFAF9Q41486362-6C5B61ED-1C40-408C-A449-5EC2BA132211Q41500540-310D8B4C-F8AB-4149-B116-115EC51266E3Q41983595-0F6AE850-F6A0-4942-A9BF-8F868B3A56F5Q43508439-2ACF7527-E105-442F-B6B3-2742282F70E9Q43605953-7704E057-7AF2-459A-B358-A6C938BC0D90Q44942945-BDEC11AA-02EB-4430-B20C-B37D892AD7E2Q45107248-DC1DA65D-1BA9-4709-842B-6F52413E65F4Q45255365-7019FE02-292C-4473-B6FF-344E122CA7C7Q46529842-F26559AF-D12E-4B7A-AC3E-000971B374DBQ46645990-D0D2C988-AF6C-45A7-B954-0599FBFEAA98Q46663117-F36D71B5-42A5-4587-8CD4-E23AC8A53C97Q48185969-D3C361D7-4DC1-4569-982D-72D65036234AQ53594501-4B931BA6-F7F7-4C52-8272-15741291C17CQ58180355-B0BB8F12-B213-4D06-B0E5-7B793C583855Q59131729-A81A95DD-9E22-4FD7-8037-EEED61527426
P2860
Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hyperhomocyst
@nl
Hyperhomocyst(e)inemia. A comm ...... for occlusive atherosclerosis.
@en
type
label
Hyperhomocyst
@nl
Hyperhomocyst(e)inemia. A comm ...... for occlusive atherosclerosis.
@en
prefLabel
Hyperhomocyst
@nl
Hyperhomocyst(e)inemia. A comm ...... for occlusive atherosclerosis.
@en
P356
P1433
P1476
Hyperhomocyst(e)inemia. A comm ...... for occlusive atherosclerosis.
@en
P2093
Malinow MR
P304
P356
10.1161/01.CIR.81.6.2004
P407
P577
1990-06-01T00:00:00Z